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Centre for Mathematical Modelling of Infectious Diseases COVID-19 Working Group* and ISARIC4C investigators*
Summary
Background A second wave of COVID-19 cases in autumn, 2020, in England led to localised, tiered restrictions 
(so-called alert levels) and, subsequently, a second national lockdown. We examined the impact of these tiered 
restrictions, and alternatives for lockdown stringency, timing, and duration, on severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) transmission and hospital admissions and deaths from COVID-19.
Methods We fit an age-structured mathematical model of SARS-CoV-2 transmission to data on hospital admissions 
and hospital bed occupancy (ISARIC4C/COVID-19 Clinical Information Network, National Health Service [NHS] 
England), seroprevalence (Office for National Statistics, UK Biobank, REACT-2 study), virology (REACT-1 study), and 
deaths (Public Health England) across the seven NHS England regions from March 1, to Oct 13, 2020. We analysed 
mobility (Google Community Mobility) and social contact (CoMix study) data to estimate the effect of tiered restrictions 
implemented in England, and of lockdowns implemented in Northern Ireland and Wales, in October, 2020, and 
projected epidemiological scenarios for England up to March 31, 2021.
Findings We estimated a reduction in the effective reproduction number (Rt) of 2% (95% credible interval [CrI] 0–4) 
for tier 2, 10% (6–14) for tier 3, 35% (30–41) for a Northern Ireland-stringency lockdown with schools closed, and 
44% (37–49) for a Wales-stringency lockdown with schools closed. From Oct 1, 2020, to March 31, 2021, a projected 
COVID-19 epidemic without tiered restrictions or lockdown results in 280 000 (95% projection interval 274 000–287 000) 
hospital admissions and 58 500 (55 800–61 100) deaths. Tiered restrictions would reduce hospital admissions to 
238 000 (231 000–245 000) and deaths to 48 600 (46 400–50 700). From Nov 5, 2020, a 4-week Wales-type lockdown with 
schools remaining open—similar to the lockdown measures announced in England in November, 2020—was 
projected to further reduce hospital admissions to 186 000 (179 000–193 000) and deaths to 36 800 (34 900–38 800). 
Closing schools was projected to further reduce hospital admissions to 157 000 (152 000–163 000) and deaths to 
30 300 (29 000–31 900). A projected lockdown of greater than 4 weeks would reduce deaths but would bring 
diminishing returns in reducing peak pressure on hospital services. An earlier lockdown would have reduced deaths 
and hospitalisations in the short term, but would lead to a faster resurgence in cases after January, 2021. In a post-hoc 
analysis, we estimated that the second lockdown in England (Nov 5–Dec 2) reduced Rt by 22% (95% CrI 15–29), rather 
than the 32% (25–39) reduction estimated for a Wales-stringency lockdown with schools open.
Interpretation Lockdown measures outperform less stringent restrictions in reducing cumulative deaths. We 
projected that the lockdown policy announced to commence in England on Nov 5, with a similar stringency to the 
lockdown adopted in Wales, would reduce pressure on the health service and would be well timed to suppress deaths 
over the winter period, while allowing schools to remain open. Following completion of the analysis, we analysed new 
data from November, 2020, and found that despite similarities in policy, the second lockdown in England had a 
smaller impact on behaviour than did the second lockdown in Wales, resulting in more deaths and hospitalisations 
than we originally projected when focusing on a Wales-stringency scenario for the lockdown.
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Introduction
The UK saw its first wave of COVID-19 cases in 
spring, 2020. Following the imposition of a national 
lockdown on March 23, 2020, with residents required to 
stay at home except for accessing medical care, daily 
exercise, shopping for essentials, and essential work 
travel, COVID-19 cases, hospital admissions, and deaths 
subsided. A resurgence of COVID-19 cases began in the 
late summer after most restrictions had been lifted. By the 
end of October, large-scale, population-based studies in 
England suggested about 50 000–100 000 new infections 
were occurring every day.1,2 This rise in infections resulted 
in pressure on health services, with 8822 confirmed 
COVID-19 cases in English hospitals on Oct 303—about 
Articles
2 www.thelancet.com/infection   Published online December 23, 2020    https://doi.org/10.1016/S1473-3099(20)30984-1
half the number observed during the previous peak in 
April—and increasing numbers of deaths. Evidence of 
substantial geographical heterogeneity began to emerge 
across England, with a national infection survey suggesting 
that in late October, around one in 45 people were infected 
in the northwest, compared with one in 200 in the 
southeast.2
On Oct 12, the UK Government announced a pro-
gramme of regionally differentiated physical distancing 
measures using a three-tiered approach, known as alert 
levels.4 By default, regions were placed into tier 1, the 
least restrictive tier, but could be moved into tiers 2 or 3 if 
incidence of infection increased. Regions in tier 1 had a 
2200 h curfew for hospitality venues and restrictions on 
the number of individuals who could meet (the so-called 
rule of six). Tier 2 regions had additional restrictions 
on individuals from different households mixing, and 
residents were advised to avoid making unnecessary 
journeys. Regions in tier 3 had additional closures of 
hospitality and leisure venues, such as pubs and 
restaurants. In the weeks following the announcement, 
the UK Government placed several local authority 
districts—particularly in the north of England—into the 
highest restriction category, tier 3. Despite these 
measures, incidence continued to rise in all regions of 
England.1,2 Consequently, on Oct 31, a new 4-week 
national lockdown for England was announced, 
beginning on Nov 5. The restrictions were broadly 
similar to those of the initial spring lockdown, but 
schools and universities were allowed to remain open. It 
remains unclear how effective the tiered restrictions 
were in reducing transmission and what additional 
reduction in transmission might have been accomplished 
by the second lockdown.
The other UK nations experienced similar resurgences 
in September, 2020, and in response to this, both 
Northern Ireland and Wales implemented time-limited 
lockdowns in mid-October. These differed in their 
stringencies, with the so-called firebreak measures in 
Wales being more comprehensive than the so-called 
circuit breaker measures in Northern Ireland. Both 
lockdowns were timed to coincide with the school half-
term vacation period.
Here, we analyse mobility and contact survey data to 
estimate the impact of tiered restrictions in England 
and of the lockdowns in Northern Ireland and Wales 
on severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) transmission. We use this analysis to 
parameterise a mathematical model fit to multiple data 
sources to estimate the impact of tiered restrictions and 
alternative scenarios regarding the timing, duration, and 
stringency of extended physical distancing measures on 
Research in context
Evidence before this study
Numerous studies have modelled the relative effects of 
non-pharmaceutical interventions on severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) transmission. 
We searched PubMed, bioRxiv, and medRxiv from database 
inception to Nov 9, 2020, for English-language articles with the 
search terms (“COVID-19” OR “SARS-CoV-2” OR “coronavirus”) 
AND (“lockdown”) AND (“model”). This search returned 
676 results, of which 23 were modelling studies that fit models 
to data and examined a second round of physical distancing 
restrictions, such as lockdowns or tiered restrictions. 19 of the 
23 studies used a model to assess the impact of lockdowns, 
often on a national scale and occasionally regionally. 
The two studies most similar to our own considered tiered 
responses in China and so-called circuit breakers in the UK. 
However, typically, the length or stringency of the lockdown 
considered were not varied.
Added value of this study
This study builds upon the existing literature in several ways. 
First, mobility measures (Google Community Mobility) and 
contact survey data (CoMix study) were used to estimate 
behavioural responses following the introduction of tiered 
restrictions in England, the so-called firebreak lockdown in 
Wales, and the so-called circuit breaker lockdown in 
Northern Ireland. Second, the model was fit to multiple data 
sources to reconstruct the dynamics of the SARS-CoV-2 
outbreak in England from March to October, 2020. 
Finally, policies for managing a second wave of COVID-19 cases 
are contrasted. Comparisons are made between a baseline 
scenario (ie, a counterfactual scenario with no tiered 
restrictions and no lockdown), implementation of tiered 
restrictions only, and implementation of tiered restrictions plus 
different-stringency lockdowns in England, with and without 
schools open. The effects of these scenarios on cumulative 
deaths, demand for hospital services, and time spent under 
restrictions are explored in relation to the type of intervention 
implemented and the duration and timing of lockdown 
interventions. Regional responses to different types, 
timings, and durations of interventions are also explored.
Implications of all the available evidence
Without the additional public health interventions adopted, 
the second wave is projected to be more severe than the first 
wave. The tiered restrictions introduced in October, 2020 
(in particular tier 3), were projected to have had some effect in 
slowing transmission, but the addition of a temporary 
lockdown provided the strongest effect in reducing COVID-19 
deaths and hospital admissions. Earlier lockdowns would have 
saved lives in the short term, but because substantial 
susceptibility would have remained in the population, 
they might have resulted in larger resurgences after 
January, 2021, requiring the introduction of further 
non-pharmaceutical interventions.
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hospital admissions and deaths due to COVID-19 in 
England.
Methods
Epidemiological model and fitting
We used a previously published dynamic compartmental 
model of SARS-CoV-2 transmission5,6 stratified into 5-year 
age bands. The model was fitted using Markov chain 
Monte Carlo methods to data reported across the 
seven National Health Service (NHS) England regions on 
hospital admissions for COVID-19, hospital and intensive 
care unit (ICU) bed occupancy related to COVID-19, 
seroprevalence, PCR positivity, and deaths within 28 days 
of an individual’s first positive SARS-CoV-2 test, which is 
used as the primary measure of COVID-19 mortality in 
the UK.7 Hospital admissions and occupancy data were 
provided by NHS England and deaths data by Public 
Health England (March 1–Oct 13). These data sources 
are unpublished and not public but are closely aligned 
with the UK Government COVID-19 Dashboard.3 
Seroprevalence data were obtained from the Office for 
National Statistics COVID-19 Infection Survey (ONS-CIS; 
May 1–Sept 30),2 the UK Biobank (May 27–Aug 14),8 and 
the REACT-2 study (June 20–Sept 28),1 and PCR-positivity 
data were obtained from the REACT-1 study (May 1–Oct 5).1
The age-specific probability of ICU admission given 
hospital admission, as well as the distributions of 
lengths of stay in hospital and in the ICU, were estimated 
using individual-patient data in the COVID-19 Clinical 
Information Network (CO-CIN), which were collected 
from an ongoing study in patients with COVID-19 in 
the UK.9 Model-fitted distributions for the delays from 
infection to death, infection to hospital admission, and 
infection to ICU admission were also informed by 
CO-CIN data. The relative age-specific infection fatality 
risk was adopted from a global meta-analysis,10 and the 
relative age-specific infection hospitalisation risk was 
adopted from a study of the COVID-19 epidemic in 
France;11 given these relative age-specific rates, the 
overall infection fatality risk, infection hospitalisation 
risk, and probability of ICU admission given 
hospitalisation were inferred for each NHS England 
region during model fitting. The age-specific fatality risk 
among patients admitted to hospital decreased 
substantially over time according to CO-CIN data;9 there-
fore, we estimated this relative decrease during model 
fitting, assuming no further change in the infection 
fatality risk from September, 2020, onwards. A full 
description of fitted and non-fitted parameters is 
provided in the appendix (pp 8–10).
Transmission rates and mobility indices
Because some of the most reliable indicators of infection—
hospital admissions and deaths—lag substantially behind 
transmission rates, it is challenging to estimate the impact 
of policy and behavioural changes on SARS-CoV-2 
transmission in real time. We measured the relationship 
between anonymised mobility data collected from smart-
phone users by Google Community Mobility12 and fine-
grained social-contact survey data from the CoMix study,13 
which has been collecting data on UK residents’ daily 
interpersonal contacts since late March, 2020. This 
approach allowed us to use indirect but rapidly available 
mobility data to predict changes in transmission resulting 
from behavioural and policy changes over time. We used 
this approach both in fitting the model to policy changes 
over the first wave of the COVID-19 epidemic in England, 
and in estimating the impact of tiered restrictions 
in England and of lockdown interventions in Northern 
Ireland and Wales (appendix pp 1–5).
Intervention scenarios
During Northern Ireland’s so-called circuit breaker 
lockdown, non-essential retail remained open and 
so-called household bubbles of up to ten people from 
two households were allowed to mix. By contrast, during 
Wales’ so-called firebreak lockdown, non-essential retail 
was closed and residents were advised to stay at home 
and were prohibited from mixing with individuals from 
outside their house holds. We therefore constructed a 
Northern Ireland-stringency lockdown scenario and a 
Wales-stringency lockdown scenario by applying the 
measured reduction in mobility in Northern Ireland and 
in Wales to England. Additionally, we modelled these 
scenarios either with schools closed or with schools open 
during lockdown. To simulate school closure, we reduced 
contact rates according to the age-specific proportion 
of contacts made at school,14 and further reduced all 
individuals’ contacts by a multiplicative factor we 
estimated during model fitting that was associated with 
the reopening of schools in England in September 
(appendix pp 7–9). We also varied the duration 
and timing of lockdown interventions. Given that 
the UK Government opted for a 4-week lockdown in 
England from Nov 5, which was similar to the Welsh 
lockdown scenario without school closures, we focus on 
this scenario for our assessment of the impact of a 
second lockdown in England, examining other possi-
bilities as sensitivity analyses. By default, we assume that 
recovery from SARS-CoV-2 infection confers lifelong 
immunity to reinfection, but we also explore a scenario 
with waning natural protection. Additionally, by default 
we assume that—except for changes imposed by 
restrictions—contact rates remained constant after the 
imposition of tiered restrictions on Oct 14; we also 
explored a scenario in which seasonal increases in 
contact patterns resulted in an increase in transmission 
over the winter period (appendix p 6). Throughout, we 
calculate 95% credible intervals (CrIs) and 95% projection 
intervals (PIs) as the 2·5th and 97·5th percentiles of 
the sampled posterior distribution for model outputs. 
The use of PIs emphasises that these intervals do not 
account for unforeseen changes in contact patterns and 
epidemiological parameters.
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Ethics
For CO-CIN data, ethical approval for data collection 
and analysis by ISARIC4C was given by the South 
Central-Oxford C Research Ethics Committee in England 
(reference 13/SC/0149) and the Scotland A Research Ethics 
Committee (reference 20/SS/0028). The ISARIC WHO 
CCP-UK study, which produced the CO-CIN data, is 
registered with the ISRCTN registry (ISRCTN66726260) 
and was designated an Urgent Public Health Research 
Study by the National Institute for Health Research.
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. NGD and RCB had full access to 
all the data in the study. The corresponding author 
Figure 1: Model fit to NHS England region-specific data from March 1, to Oct 14, 2020
NHS England region-specific data on the number of COVID-19 deaths, hospital admissions, and occupied hospital and ICU beds; proportion of residents PCR positive and seropositive; and the regional 
attack rate (proportion ever infected). Black lines show reported data. Coloured lines and shaded areas show medians and 95% credible intervals from the fitted model. The crosses on the PCR positivity 
and seropositivity graphs show the time period over which the data were collected (horizontal lines) and the 95% CIs associated with the data (vertical lines). ICU=intensive care unit. 
NHS=National Health Service.
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had final responsibility for the decision to submit for 
publication.
Results
Our fitted model captures the observed dynamics of 
community transmission of SARS-CoV-2 during the first 
and second waves from March 1, to Oct 13, 2020 
(figure 1), reproducing region-specific observed infections, 
seropositivity, deaths, hospital admissions, and ICU and 
hospital bed occupancies. In addition, the model was 
capable of accurately forecasting the changes in numbers 
of deaths, hospital admissions, and hospital beds occupied 
during the autumn period, although it overestimated ICU 
occupancy due to a sharp decline in the proportion of 
patients admitted to hospital who were admitted to the 
ICU after mid-September (appendix pp 12–16).
Under our base-case assumption of no waning immunity 
and no seasonal increase in contacts, and without the 
imposition of tiered restrictions or any other lockdown 
intervention, the model suggests that hospital admissions 
would peak in the North West around mid-November, with 
other regions peaking somewhat later over the winter 
period (appendix p 22). By March 31, 2021, around 35–46% 
of the population in each region is expected to have been 
infected (appendix p 34). Under this baseline scenario, 
from Oct 1, 2020, to March 31, 2021, the epidemic is 
projected to result in 280 000 (95% PI 274 000–287 000) 
hospital admissions and 58 500 (55 800–61 100) deaths, 
with a peak ICU occupancy of 5000 (4840–5170) beds 
(table 1). For the first wave (up to Sept 30), our fitted model 
estimates there were 127 000 (125 000–128 000) hospital 
admissions and 36 900 (36 200–37 500) deaths, and that 
the peak ICU occupancy was 3090 (3020–3130) beds. 
Therefore, the expected scale of the second wave, without 
any interventions, is larger than the first on all three of 
these key metrics. Crucially, this baseline scenario for the 
second wave is not equivalent to a completely unmitigated 
epidemic, as social contacts have not returned to their 
prepandemic rates in England (appendix pp 1–2), and 
the incidence of infection is also blunted by immunity 
acquired during the first wave. There are, however, 
expected to be considerable differences between regions 
in the epidemic burden, with the greatest number 
of admissions and deaths projected for the Midlands, 
North East and Yorkshire, and North West regions 
(appendix p 28).
Baseline scenario Tiers only Northern Ireland-type lockdown Wales-type lockdown
Schools open Schools closed Schools open Schools closed
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Medians and 95% projection intervals are shown. Weeks of high ICU occupancy are calculated by measuring the number of weeks in each region where ICU occupancy is 
50% or greater than the peak occupancy during the first wave. Lockdowns are assumed to run from Nov 5 to Dec 2, 2020 (eg, 3·9 weeks), inclusively. ICU=intensive care unit. 
*Relative to the peak ICU occupancy in March–May, 2020 (the first wave). †The underlying quantity is the population-weighted mean time spent living under restrictions 
across all seven National Health Service England regions.
Table 1: Model projections in England for the period of Oct 1, 2020, to March 31, 2021
Reduction in Rt
Tier 2 2% (0–4)
Tier 3 10% (6–14)
Northern Ireland-type lockdown
Schools closed 35% (30–41)
Schools open 22% (15–27)
Wales-type lockdown
Schools closed 44% (37–49)
Schools open 32% (25–39)
England lockdown
Schools closed 36% (29–42)
Schools open 22% (15–29)
Data are % (95% credible interval). The reduction in Rt is relative to immediately 
before the control measure was introduced. Rt=effective reproduction number. 
SARS-CoV-2=severe acute respiratory syndrome coronavirus 2.
Table 2: Estimated effect of tiered restrictions and lockdowns on Rt of 
SARS-CoV-2 in England
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Our analysis of mobility indicators suggests that tier 3 
restrictions are associated with a substantially greater 
reduction in mobility than are tier 2 restrictions. In turn, 
both lockdowns are associated with a greater reduction 
in mobility than are tier 3 restrictions, with the fire break 
lockdown in Wales having a substantially greater 
effect than the circuit breaker in Northern Ireland 
(appendix pp 2–5). In turn, these reductions in mobility 
are estimated to reduce the effective reproduction 
number (Rt) by 2% (95% CrI 0–4) for tier 2, 10% (6–14) for 
tier 3, 35% (30–41) for a Northern Ireland-stringency 
lockdown with schools closed, and 44% (37–49) for a 
Wales-stringency lockdown with schools closed (table 2). 
When we introduce tiered restrictions into our model on 
Oct 14, 2020, the projected number of hospital admissions 
from Oct 1, 2020, to March 31, 2021, decreases to 
238 000 (95% PI 231 000–245 000), of deaths to 
48 600 (46 400–50 700), and of number of beds occupied at 
peak ICU occupancy to 3900 (3800–4010; table 1).
The model projects a reduction in transmission across 
all NHS England regions following the introduction 
of a 4-week Wales-type lockdown (figure 2), with the 
closure of schools resulting in additional reductions in 
transmission. Rt is suppressed to below one during 
lock down periods. In most regions, following the 
lockdown period, Rt initially increases above one before 
reducing over time. This rebound occurs because there 
is insufficient immunity in the population, and so as 
restrictions are eased, transmission increases. By 
contrast, in the most heavily affected regions (ie, the 
North West), the easing of lockdown is not expected to 
result in a rebound of infections as accumulated 
population immunity retains Rt below one. We observe 
similar results (including reduction of Rt below one in 
all regions) upon the introduction of a Northern Ireland-
type lockdown (appendix p 23), but with weaker effects. 
Region-specific effects on hospital admissions, deaths, 
ICU burden, and length of time spent under different 
measures for different lockdown scenarios are shown in 
the appendix (pp 30–33). The model predicts that the 
North East and Yorkshire, North West, and South West 
regions exceed the peak ICU occupancy observed 
during the first wave for all four lockdown scenarios 
considered.
Figure 2: Projected impact of a Wales-type lockdown in NHS England regions
Rt, the daily number of deaths and hospital admissions, and the daily number of occupied hospital and ICU beds are compared across seven NHS England regions for three different scenarios: tiered 
restrictions only and a Wales-type lockdown with and without schools open. Lockdowns extend from Nov 5, to Dec 2, 2020 (indicated by grey shading on the graphs). Lines and green, red, or blue 
shaded ribbons indicate median and 95% projection intervals, respectively. Step changes in Rt show the introduction or relaxation of tiered restrictions and lockdown measures. ICU=intensive care unit. 
NHS=National Health Service. Rt=effective reproduction number.
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For the tiers-only scenarios, Rt decreases over time and 
remains below the levels expected with the introduction 
of a lockdown (figure 2; appendix p 23). This difference is 
due to greater depletion of susceptible individuals under 
tiered restrictions than with a lockdown; lockdowns 
reduce infections in the short term and therefore result 
in less population immunity.
Lockdown measures consistently outperform the base-
line and tiered restrictions in reducing cumulative deaths 
over the time period considered (figure 3A). The higher 
the stringency of the lockdown and the longer the 
duration, the greater reduction in deaths (figure 3A, B). 
To substantially reduce pressure on health services, at 
least a Northern Ireland-type lockdown with schools 
closed (or a Wales-type lockdown with schools open) is 
required. Under a Wales-type lockdown with schools 
open, longer lockdown lengths result in lower numbers 
of cumulative deaths over time as well as reduced 
hospital pressure (figure 3B). Lockdowns also reduce the 
median time spent living under tiers 2 and 3 restrictions 
Figure 3: Projected impact of altering the type of intervention or duration or timing of lockdown on cumulative deaths, pressure on hospitals, and time spent living under restrictions
(A) Impact of altering the type of intervention. Baseline refers to a counterfactual scenario with no tiered restrictions and no lockdown. Note that the lines for NI with and without schools closed 
overlap in the top graph. (B) Impact of altering the duration of lockdown. Graphs show the effects of introducing different lengths of a Wales-type lockdown (with schools open) in England on 
Nov 5, assuming tiered restrictions are already in place. (C) Impact of altering the timing of lockdown. Graphs show the effects of varying the time a 4-week, Wales-type lockdown (with schools open) 
is introduced in England, starting from up to 4 weeks before to 2 weeks after Nov 5. Hospital pressure was defined as the population-weighted mean number of weeks that an National Health Service 
region’s hospital or ICU bed occupancy exceeded 50% of the peak occupancy for that region during the first wave of COVID-19 in England. All graphs show medians, with shaded regions defining 
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(figure 3A, B), illustrating that these interventions trade 
off against each other.
When a lockdown intervention is introduced earlier, 
the rise in deaths is suppressed sooner (figure 3C). 
However, by the end of March, 2021, we observe that 
scenarios with an earlier lockdown reach a higher 
cumulative number of deaths. This larger burden is 
because earlier lockdowns result in longer periods of 
inflated transmission following the end of the periods 
of restrictions. In reality, we expect that additional 
interventions would be introduced before this level of 
transmission is reached.
The best timing of a single 4-week lockdown, in terms 
of reductions in deaths and hospital pressure over the 
period considered, appears to be around early to 
mid-November, 2020 (figure 3C). This result is predicated 
upon only one 4-week lockdown being introduced, and 
takes as given the high level of SARS-CoV-2 transmission 
observed in England in autumn 2020. The effects on 
deaths, hospital admissions, cases, infections, hospital 
burden, ICU burden, and the median time spent under 
restrictions for different intervention strategies and 
lockdown durations and timings were also explored 
(figure 3), and substantial variation was observed among 
regions, with the North West, North East and Yorkshire, 
and Midlands regions experiencing the greatest burdens 
(appendix p 24).
Table 3 shows the results of sensitivity analyses that 
include waning immunity, seasonal increases in contact 
patterns, or both, for the Wales-type lockdown without 
school closures (closest to the measures adopted in 
England) and for the tiers-only scenario. Both waning 
immunity and increases in mixing due to seasonal factors 
are expected to exacerbate the second wave. For instance, 
for the tiers-only scenario, seasonality is expected to 
increase demand for hospital beds and deaths by 
about 20%, waning immunity by about 25%, and both 
waning immunity and seasonality by about 50%. 
Increasing transmission over the winter period as a result 
of either or both of these factors diminishes the impact of 
the temporary lockdown, both in absolute and relative 
terms. For instance, under the baseline scenario, the 
4-week November lockdown was expected to reduce 
hospital admissions by about 52 000 between October, 2020, 
and March 2021, a 21% reduction. However, if both waning 
immunity and seasonality occur, introducing the same 
temporary lockdown would only be expected to reduce 
hospital admissions by about 31 000 over the same time 
period (a 9% reduction), as the rebound in infections after 
the lockdown would be more rapid under this scenario 
(appendix pp 25–27).
These analyses were originally conducted during 
late October and early November, 2020, when the 
decisions over a lockdown in England were being made. 
At the end of November, we assessed the actual impact of 
the lockdown in England on observed mobility and used 
these estimates to update our projections. The lockdown 
in England had an effect on mobility that was intermediate 
between the effects of the lockdowns in Wales and 
Northern Ireland (table 2; appendix pp 4–5). Qualitatively, 
the projected impact of the 4-week lockdown in England 
on estimated cumulative deaths, hospital pressure, and 
























































































































Time in lockdown, 
weeks†
0 (0–0) 3·86 
(3·86–3·86)
0 (0–0) 3·86 
(3·86–3·86)
0 (0–0) 3·86 
(3·86–3·86)
0 (0–0) 3·86 
(3·86–3·86)




















Medians and 95% projection intervals are shown. Burdens are summed over the period from Oct 1, 2020, to March 31, 2021. Here, the lockdown scenario uses the assumption of a Wales-type lockdown with 
schools open. Lockdowns are assumed to run from Nov 5, to Dec 2, 2020, inclusively. Seasonal contact patterns and waning protection from reinfection take effect on Oct 1, 2020. ICU=intensive care unit. 
*Relative to the peak ICU occupancy in March–May, 2020 (the first wave). †The underlying quantity is the population-weighted mean time spent living under restrictions across all seven National Health Service 
England regions.
Table 3: Sensitivity analysis for scenarios with a seasonal increase in contact rates, waning immunity, or both
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time spent under different restrictions is similar to our 
base-case analysis, but the lower impact of the lockdown 
on behaviour means that the distinction between the 
effects of alternative policies in terms of timing and 
duration is less marked than with the base-case scenario 
(appendix pp 7, 11–12).
Discussion
Without additional restrictions, the second wave of 
COVID-19 in England is projected to be more severe than 
the first wave in terms of hospital admissions and 
deaths. Tiered restrictions, and in particular the most 
stringent tier 3, probably helped to slow transmission, 
although these restrictions have a much lesser effect on 
reducing hospital admissions and deaths than do 
lockdown scenarios. We projected that a 4-week lockdown 
intervention would probably have a strong but temporary 
effect, reducing Rt to well below one during the lockdown 
period, with sustained reductions in cases, deaths, and 
hospital admissions for several months afterwards. After 
easement of the lockdown, we do not expect a large surge 
in cases if tiered restrictions remain in place, because 
in most NHS England regions we project there will 
be sufficient depletion of susceptible individuals—
given transmission and contact rates as of early 
December, 2020—to keep Rt below, or close to, one. 
However, outbreaks could still occur, particularly in areas 
with previously low incidence. If there is a seasonal 
increase in transmission during winter, substantial 
waning immunity, or a relaxation in control measures 
including tiered restrictions, there could be a larger 
resurgence in transmission.
Among the lockdown scenarios we considered, the 
timing of lockdown as enacted in England (Nov 5) is 
roughly consistent with the largest reduction in deaths and 
least pressure on health services. An earlier lockdown is 
projected to have saved more lives up to the end of 
January, 2021, but might have resulted in a larger 
resurgence in February and March, 2021, in the absence of 
additional measures (figure 3). These conclusions are 
broadly in line with other studies considering the impact of 
tiered restrictions and lockdown interventions. A network-
based study considering the effect of tiered restrictions in 
China concluded that later implementation of lockdowns 
and physical distancing measures signi ficantly increases 
the total number of infections.15 Another study looking at 
short-term, so-called circuit breaker interventions in 
the UK found that such interventions have the biggest 
impact when the growth rate is low.16 The authors concluded 
that such inter ventions are not long-term solutions but can 
buy time to improve other control measures, such as 
testing, contact tracing and isolation, or introduction of 
a vaccine.
We arrived at our conclusions by jointly fitting our 
age-structured transmission model of SARS-CoV-2 to 
the following data sources: observed hospital admissions, 
hospital and ICU bed occupancy, seroprevalence, 
PCR positivity, and deaths. The model fit well to these data 
streams and predicted the time course of hospital 
admissions and deaths accurately over the course of the 
autumn, giving some confidence in the results shown 
here (appendix pp 12–16, 21). The inability of the model 
to accurately predict the level of tiered restrictions 
that two regions were placed under by the end of 
October, 2020 (appendix p 13), emphasises the difficulty of 
predicting political decisions. Projecting the epidemic 
over long time frames is inherently uncertain for many 
reasons, including that new interventions (such as 
mass screening or vaccination) might be introduced. 
Accordingly, these results should be taken as indicative of 
what might be expected if current policies remain in place, 
with a return to tiered restrictions after lockdown, rather 
than forecasts or predictions. For these reasons, we also 
chose the end of March, 2021, as the longest timescale to 
model. Indeed, the roll-out of vaccines is now underway.17 
The availability of a vaccine might foreshorten the 
appropriate time frame for this analysis, placing further 
weight on the importance of prompt action to curb the 
second wave, although it will still be several months before 
vaccination starts to have a population-level impact.
Our model is subject to certain limitations and 
uncertainties, a number of which have previously been 
discussed in detail.5,6 First, we do not consider the 
implementation of any further interventions after the 
lockdown periods considered, aside from a continuation 
of tiered restrictions at the level imposed before the 
lockdown. Second, for the majority of scenarios 
considered, we have assumed that once individuals have 
been infected with SARS-CoV-2 and recovered, their 
immunity is maintained over the time frames modelled. 
There is emerging evidence to suggest that reinfection 
with SARS-CoV-2 is possible, although rare.18 At present it 
is unclear how widespread reinfection events are, on what 
timescale these reinfection events might occur, and 
whether reinfection results in greater or lesser severity of 
disease.19 Given that we have projected that all regions of 
England are likely to have an Rt close to the critical 
threshold of one through to winter and early spring, 2021, 
relatively small changes in the level of natural immunity 
could have a substantial impact on predictions.
Although not the main focus of the work, we explored 
the effects of seasonal contact patterns and waning 
protection from reinfection, both of which worsen 
outcomes (table 3). Changes in behaviour are likely to 
occur over the time frames that we are modelling, 
particularly over the Christmas period. Behavioural 
changes are difficult to predict, and it is possible that 
there will be a return to more typical behaviours after 
the lockdown, or indeed a continuation of cautious 
behaviours, as was observed after the spring lockdown 
ended. We have not attempted to capture these possible 
changes; an improved understanding of how behaviours 
might alter in light of changes in risk and government 
advice is urgently needed to improve the longer-term 
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accuracy of modelling studies. Moreover, it should be 
stressed that this model only considers morbidity and 
mortality directly related to COVID-19 (and might even 
underestimate COVID-19-related mortality due to the 
use of the standard definition for deaths related to 
COVID-19 within the UK—ie, death within 28 days of an 
individual’s first COVID-19 test). There are a range of 
other COVID-19-related outcomes related to short-term 
illness and long-term sequelae that we do not consider 
here. There are also many indirect health effects that can 
result from disruption to health services, for which our 
measures of health service pressure are only a rough 
proxy. Moreover, there are multiple social, psychological, 
economic, and (for children) developmental costs and 
loss of educational opportunity, both in the short and 
longer term, resulting from interventions. We focus on 
direct epidemiological implications for COVID-19 and do 
not attempt to measure wider effects here, but we 
acknowledge that they must be taken into account when 
deciding on a course of action. Finally, our analysis was 
conducted before the emergence of the novel SARS-
CoV-2 variant of concern 202012/01 in England, which 
might lead to increased transmissibility over the winter 
period.20 The potential for the emergence of more 
virulent strains of SARS-CoV-2 emphasises the need to 
quantify the effect of alternative non-pharmaceutical 
control measures, so that effective evidence-based policy 
can be made in response to developing circumstances. 
Crucially, we evaluated the efficacy of control measures 
by estimating their effect on mobility and contact 
patterns rather than on the incidence of infection. This 
means that our assessment of the effect of control 
measures on mobility in England (appendix pp 1–5) is 
not confounded by any increase in transmission owing 
to the emergence of the new variant.
Faced with rising COVID-19 cases and resulting 
pressure on health systems, countries across Europe 
have tried to adopt measures that maximise the 
suppression of transmission while minimising social 
and economic harms. Many have chosen to reintroduce 
strict measures such as lockdowns. In England, the 
government introduced a second national lockdown 
starting on Nov 5, 2020. We estimate that this lockdown 
will reduce COVID-19 deaths and ease the pressure on 
health services over the winter of 2020–21. More stringent 
or lengthy interventions could reduce deaths and hospital 
pressure further, but these benefits need to be weighed 
against the heavier social and economic costs associated 
with stricter measures.
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